Share:
Peer-Reviewed Publication
Bioinformatics2026June 4, 2026Journal Article

A computational analysis of the glycoprotein LRP1 structure and the role of glycans as quaternary glue.

Gian Marco Tuveri1, Marco Basile2, Silvia Acosta Gutiérrez3, Marius Kausas4, Silvia Pujals5, Xiaohe Tian6, Giancarlo Franzese6, Lorena Ruiz Pérez7, Giuseppe Battaglia8
1Institute for Bioengineering of Catalunya (IBEC), The Barcelona Institute of Science and Technology (BIST), c/ Baldiri Reixac, 10-12, 08028, Barcelona, Spain.
2Department of Biomedicine, University of Barcelona, c/ Martí i Franquès 1, 08028, Barcelona, Spain.
3InstaDeep Ltd, 1 Triton Square, NW1 3BF, London, United Kingdom.
4Vianautis Bio ltd, Cadence, Unity Campus, CB22 3FT, Cambridge, United Kingdom.
5Department of Biological Chemistry, Institute for Advanced Chemistry of Catalonia, c/ Jordi Girona, 18-26, 08034, Barcelona, Spain.
6Department of Radiology and Huaxi MR Research Center (HMRRC), Functional and Molecular Imaging Key Laboratory of Sichuan Province, Department of Radiology and National Clinical Research Center for Geriatrics, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy, West China Hospital of Sichuan University, Chengdu, 610000, Sichuan Province, China.
7Department of Applied Physics, University of Barcelona, c/ Martí i Franquès 1, 08028, Barcelona, Spain.
8Catalan Institution for Research and Advanced Studies (ICREA), Passeig Lluís Companys 23, 08010, Barcelona, Spain.

Abstract

MOTIVATION: The low-density lipoprotein receptor-related protein 1 (LRP1) plays a critical role in development and transport across the blood-brain barrier (BBB), yet its molecular architecture has remained unresolved due to the absence of an experimentally determined structure. RESULTS: Using homology modelling and neural network-based structure prediction algorithms, complemented with molecular…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.